Issue 1/2010
Content (9 Articles)
Editorial
The search for optimal response prediction in cancer leads to a personalized approach
Eric Van Cutsem, Fortunato Ciardiello
Review
Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer
Andrea Sartore-Bianchi, Katia Bencardino, Federica Di Nicolantonio, Federico Pozzi, Chiara Funaioli, Valentina Gambi, Sabrina Arena, Miriam Martini, Simona Lamba, Andrea Cassingena, Roberta Schiavo, Alberto Bardelli, Salvatore Siena
Review
Molecular response prediction in gastrointestinal stromal tumors
Philippe A. Cassier, Jean-Yves Blay
Review
Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy
Anwar R. Padhani, Aftab Alam Khan
Review
Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment
Nathalie Lassau, Mohamed Chebil, Linda Chami, Sophie Bidault, Elizabeth Girard, Alain Roche
Day-to-Day Practice
Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report
Sean Xiang Wang, Abigail Byrnes, Sadhna Verma, John R. Pancoast, Olivier Rixe
Perspectives
Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents
Christophe Le Tourneau, Véronique Diéras, Patricia Tresca, Wulfran Cacheux, Xavier Paoletti